Leveraging Genomics and AI for Precision Infectious Disease Insights

Diagnosing and researching infectious disease is challenging, with a high rate of diagnostic failure resulting in high mortality and alarming levels of drug resistance. Culturing, the current gold standard and technology from the 1800s, misses many important pathogens and requires many labor intensive tests. Even newer PCR-based tests are limited, problematic and don’t provide drug resistance information.

We work with clinicians and researchers to leverage high-complexity tests and artificial intelligence for rapid precision infectious disease discovery to guide patient treatment and improve health outcomes.

Our Mission

Fighting infectious disease with AI and genomics while developing the world’s leading microbial sequence database.

Biotia Beginnings Video